Literature DB >> 21104379

Endocannabinoid receptor pharmacology.

Betty Yao1, Ken Mackie.   

Abstract

This chapter will review the basic pharmacology of endocannabinoid receptors. As the best-described cannabinoid receptors are G-protein-coupled receptors (GPCRs), those will be the focus of this chapter. We will start with a basic review of GPCR signaling, as these concepts are critical to understanding the function of cannabinoid receptors. Next, several features of cannabinoid receptor signaling will be presented, with an emphasis on the effectors modulated by cannabinoid receptors. Finally, we will finish with a discussion of cannabinoid receptor agonists and antagonists and future directions. The aim of this chapter is to introduce the cannabinoid receptor pharmacology that will be necessary to appreciate the intricacies of endocannabinoid signaling presented in later chapters.

Mesh:

Substances:

Year:  2009        PMID: 21104379     DOI: 10.1007/978-3-540-88955-7_2

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  16 in total

1.  Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment.

Authors:  L Cinnamon Bidwell; Jarrod M Ellingson; Hollis C Karoly; Sophie L YorkWilliams; Leah N Hitchcock; Brian L Tracy; Jost Klawitter; Cristina Sempio; Angela D Bryan; Kent E Hutchison
Journal:  JAMA Psychiatry       Date:  2020-08-01       Impact factor: 21.596

Review 2.  CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?

Authors:  Amey Dhopeshwarkar; Ken Mackie
Journal:  Mol Pharmacol       Date:  2014-08-08       Impact factor: 4.436

Review 3.  Terpenes and lipids of the endocannabinoid and transient-receptor-potential-channel biosignaling systems.

Authors:  David R Janero; Alexandros Makriyannis
Journal:  ACS Chem Neurosci       Date:  2014-06-05       Impact factor: 4.418

4.  A synthetic cannabinoid JWH-210 reduces lymphoid organ weights and T-cell activator levels in mice via CB2 receptors.

Authors:  Sun Mi Gu; Hyun Jin Lee; Tac-Hyung Lee; Yun Jeong Song; Young-Hoon Kim; Kyoung-Moon Han; Jisoon Shin; Hye-Kyung Park; Hyung Soo Kim; Hye Jin Cha; Jaesuk Yun
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-08-22       Impact factor: 3.000

Review 5.  The endocrinology of taste receptors.

Authors:  Sara Santa-Cruz Calvo; Josephine M Egan
Journal:  Nat Rev Endocrinol       Date:  2015-02-24       Impact factor: 43.330

Review 6.  Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation.

Authors:  Slava Rom; Yuri Persidsky
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-08       Impact factor: 4.147

Review 7.  Peripheral gating of pain signals by endogenous lipid mediators.

Authors:  Daniele Piomelli; Oscar Sasso
Journal:  Nat Neurosci       Date:  2014-01-28       Impact factor: 24.884

8.  Synthetic Cannabinoid-Induced Immunosuppression Augments Cerebellar Dysfunction in Tetanus-Toxin Treated Mice.

Authors:  Jaesuk Yun; Sun Mi Gu; Tac-Hyung Lee; Yun Jeong Song; Seonhwa Seong; Young-Hoon Kim; Hye Jin Cha; Kyoung Moon Han; Jisoon Shin; Hokyung Oh; Kikyung Jung; Chiyoung Ahn; Hye-Kyung Park; Hyung Soo Kim
Journal:  Biomol Ther (Seoul)       Date:  2017-05-01       Impact factor: 4.634

Review 9.  CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity.

Authors:  Arnau Busquets-Garcia; Jaideep Bains; Giovanni Marsicano
Journal:  Neuropsychopharmacology       Date:  2017-09-01       Impact factor: 7.853

10.  Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease.

Authors:  Cheng Yin Yuan; Vivian Zhou; Garrett Sauber; Todd Stollenwerk; Richard Komorowski; Alicia López; Rosa María Tolón; Julian Romero; Cecilia J Hillard; William R Drobyski
Journal:  Blood       Date:  2021-03-04       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.